Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ampharco U.S.A is a prominent pharmaceutical manufacturer based in Vietnam, specializing in the production and distribution of generic prescription and over-the-counter medicines. The company operates a state-of-the-art facility that is WHO-GMP, GLP, and GSP certified, ensuring high standards of quality across its diverse product portfolio. Its therapeutic focus includes cardiovascular health, pain management, respiratory care, and anti-infectives. In addition to its own branded generics, Ampharco U.S.A provides contract manufacturing and development services to international pharmaceutical partners. The company aims to provide affordable, high-quality healthcare solutions to the Vietnamese market and beyond. Originally founded with technology transfer from the United States, it has grown into one of the leading domestic players in the Vietnamese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ampharco USA.